Ozempic is synonymous with weight loss for many people. Doctors explain benefits and risks of semaglutide and other GLP-1 ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Carolina Rudah / iStock What is the Maximum Recommended Semaglutide Dose for Weight Loss? The maximum recommended semaglutide dose for weight loss is 2.4 milligrams (mg) per week. Your healthcare ...

"Yo-yo" dieting --- repeatedly losing and gaining weight -- can significantly increase risk of kidney disease among people ...

Use of a sodium-glucose cotransporter 2, or SGLT2, inhibitor combined with calorie restriction resulted in greater rates of type 2 diabetes remission compared with calorie restriction alone, according ...

People with type 1 diabetes risk getting kidney disease if they engage in so-called yo-yo dieting, a team of French doctors warns. The danger applies regardless of a patient's weight or other diabetes ...

New research uncovers hidden risks and surprising benefits of weight loss drugs like Ozempic, reshaping how we see these ...

Additionally, the risk of weight ... and unintended weight loss. If you have questions about how much protein you should be eating, talk to your healthcare provider. You can also discuss protein with ...

Sugar-sweetened beverage intake, gut microbiota, circulating metabolites, and diabetes risk in Hispanic Community Health Study/Study of Latinos. Cell Metabolism , 2025; DOI: 10.1016/j.cmet.2024.12.004 ...

Love puri but worried about consuming extra calories? No worries! Try these simple hacks to make it weight-loss friendly. Read on to know more about it. Puri is one of the most beloved Indian breads ...

Tuesday’s financial results included a $3.8 billion loss for Boeing in the last three months of 2024. EVERETT — Boeing CEO Kelly Ortberg sees increased aircraft production in its troubled ...

Moran Eye Center at the University of Utah have published an investigatory review of nine patients who experienced vision complications while taking popular semaglutide and tirzepatide drugs ...